Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $360,645 | 241 | 91.8% |
| Travel and Lodging | $18,624 | 82 | 4.7% |
| Food and Beverage | $7,470 | 170 | 1.9% |
| Consulting Fee | $6,024 | 4 | 1.5% |
| Education | $96.81 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $234,404 | 230 | $0 (2024) |
| Lilly USA, LLC | $145,609 | 208 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $11,546 | 11 | $0 (2019) |
| Novo Nordisk Inc | $322.57 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $271.12 | 16 | $0 (2024) |
| CapsoPro Services LLC | $200.00 | 1 | $0 (2020) |
| Boston Scientific Corporation | $133.12 | 4 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.16 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $65.59 | 4 | $0 (2023) |
| PFIZER INC. | $59.86 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,057 | 53 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39,252) |
| 2023 | $55,939 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($43,285) |
| 2022 | $70,789 | 74 | Boehringer Ingelheim Pharmaceuticals, Inc. ($57,508) |
| 2021 | $67,917 | 79 | Lilly USA, LLC ($38,285) |
| 2020 | $68,181 | 81 | Lilly USA, LLC ($36,305) |
| 2019 | $82,739 | 137 | Lilly USA, LLC ($39,009) |
| 2018 | $1,146 | 5 | AstraZeneca Pharmaceuticals LP ($1,074) |
| 2017 | $92.70 | 5 | Novartis Pharmaceuticals Corporation ($39.72) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $56.28 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $27.74 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,075.00 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $117.66 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $104.52 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: DIABETES | ||||||
| 07/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $39.93 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 06/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,692 | 1,880 | $212,940 | $79,480 |
| 2022 | 18 | 1,737 | 1,977 | $202,612 | $74,783 |
| 2021 | 25 | 1,732 | 1,886 | $199,884 | $83,844 |
| 2020 | 20 | 1,478 | 1,620 | $159,949 | $59,982 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 321 | 375 | $70,125 | $31,248 | 44.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 232 | 234 | $34,632 | $11,317 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $22,116 | $8,392 | 37.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 61 | $21,899 | $8,011 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $8,820 | $3,637 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 321 | 374 | $16,082 | $3,585 | 22.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 51 | 51 | $7,905 | $2,838 | 35.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 25 | $4,575 | $1,557 | 34.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 110 | 110 | $5,060 | $1,545 | 30.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 18 | 19 | $4,864 | $1,518 | 31.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 196 | 245 | $4,410 | $1,458 | 33.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 15 | $3,210 | $1,250 | 38.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 34 | 37 | $3,120 | $1,051 | 33.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 33 | 34 | $1,700 | $602.33 | 35.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 53 | 53 | $1,590 | $545.06 | 34.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 17 | 24 | $1,056 | $366.39 | 34.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 36 | 38 | $608.00 | $196.35 | 32.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 12 | 12 | $456.00 | $152.24 | 33.4% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 14 | 14 | $336.00 | $110.28 | 32.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 45 | 47 | $376.00 | $102.77 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 326 | 387 | $72,369 | $31,310 | 43.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 257 | 261 | $38,628 | $12,248 | 31.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 58 | $20,822 | $8,595 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $19,788 | $7,684 | 38.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 367 | 462 | $19,866 | $4,369 | 22.0% |
About Dr. Gregory Lam, M.D
Dr. Gregory Lam, M.D is a Internal Medicine healthcare provider based in Circleville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255319760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Lam, M.D has received a total of $392,860 in payments from pharmaceutical and medical device companies, with $46,057 received in 2024. These payments were reported across 500 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($360,645).
As a Medicare-enrolled provider, Lam has provided services to 6,639 Medicare beneficiaries, totaling 7,363 services with total Medicare billing of $298,090. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Circleville, OH
- Active Since 01/04/2006
- Last Updated 01/05/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1255319760
Products in Payments
- JARDIANCE (Drug) $376,278
- FARXIGA (Drug) $1,074
- ENTRESTO (Drug) $190.10
- Wegovy (Drug) $177.47
- GATTEX (Drug) $112.54
- LEQVIO (Drug) $81.02
- EXALT BX 4 (Device) $72.50
- XIFAXAN (Drug) $65.59
- VYNDAQEL (Drug) $59.86
- Ozempic (Drug) $48.27
- Repatha (Biological) $36.21
- Ranexa (Drug) $27.10
- ELIQUIS (Drug) $25.88
- SPYGLASS (Device) $22.39
- ACQUIRE (Device) $21.90
- EOHILIA (Drug) $20.06
- Rybelsus (Drug) $19.87
- ENERGEN (Device) $16.33
- NEXLETOL (Drug) $13.17
- Saxenda (Drug) $12.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Circleville
Dr. Lisette Dominguez, Do, DO
Internal Medicine — Payments: $87,391
Daniel Mudrick, Md, MD
Internal Medicine — Payments: $15,878
Yadwinder Singh, Md, MD
Internal Medicine — Payments: $1,141
Allen Reeves
Internal Medicine — Payments: $766.53
Arnold Palmer, Do, DO
Internal Medicine — Payments: $611.39
Robert Violette, D.o, D.O
Internal Medicine — Payments: $572.68